ProPhase Labs (PRPH) Scheduled to Post Earnings on Thursday

ProPhase Labs (NASDAQ:PRPH) will be releasing its earnings data before the market opens on Thursday, May 9th. Analysts expect ProPhase Labs to post earnings of ($0.28) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

ProPhase Labs (NASDAQ:PRPH) last posted its quarterly earnings data on Thursday, March 28th. The company reported ($0.51) EPS for the quarter. ProPhase Labs had a negative net margin of 37.81% and a negative return on equity of 29.83%. The firm had revenue of $3.50 million during the quarter, compared to analysts’ expectations of $10.71 million. On average, analysts expect ProPhase Labs to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

ProPhase Labs Price Performance

ProPhase Labs stock opened at $5.06 on Wednesday. ProPhase Labs has a 52 week low of $4.05 and a 52 week high of $9.94. The company’s 50 day moving average price is $5.54 and its two-hundred day moving average price is $5.04. The stock has a market cap of $91.33 million, a P/E ratio of -5.16 and a beta of -0.17. The company has a quick ratio of 2.10, a current ratio of 2.28 and a debt-to-equity ratio of 0.29.

Analyst Ratings Changes

Separately, HC Wainwright reissued a “buy” rating and issued a $11.00 price objective on shares of ProPhase Labs in a research report on Wednesday, February 21st.

ProPhase Labs Company Profile

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.